LECT2 and neoplasm: In terms of cancer, LECT2 has been shown to act as a tumor suppressor in multiple cancers, such as hepatocellular carcinoma, non-small cell lung cancer, and intestinal cancer (Chen et al., 2014, 2016; Greenow et al., 2018; Hung et al., 2018; L’Hermitte et al., 2019).